Printer Friendly

Immunology study finds decreased activation markers related to better viral control.

This study measured 60 immune-system parameters over 48 weeks, in 192 antiretroviral-experienced children from 4 months to 17 years old. The results "suggest that significant decreases in the expression of activation markers and increases in the expression of naive markers in the CD8+ T cell population may be related to better virologic control in these HIV-l-infected children, who had relatively stable immune function at the initiation of HAART. At week 44 of HAART, the major immunological parameters in these HIV-l-infected children moved from baseline values to about halfway to two-thirds of the way toward the values in healthy, uninfected children." (quote from the abstract)

Comment: This is a kind of study that has been needed for a long time, to measure immune changes in patients and correlate them with virologic and/or clinical outcomes. These studies can be done in children because, for political reasons and also due to the success of preventing maternal transmission, the amount of money for AIDS research for children is disproportionate to the number of U.S. cases. Immunological studies in patients have lagged far behind antiviral studies, since there is little commercial interest in them, as there are no approved immune treatments for HIV infection. Fortunately this study could be done because one political influence on research helped to correct another.

Reference: Rosenblatt HM, Stanley KE, Song LY and others. Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection. Journal of Infectious Diseases. August l, 2005; volume 192, number 3, pages 445-455.
COPYRIGHT 2005 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Author:James, John S.
Publication:AIDS Treatment News
Date:Jun 24, 2005
Previous Article:Major study of "discordant" response--viral control but incomplete CD4 response.
Next Article:Four antiretrovirals reduced to three after 48 weeks.

Related Articles
HIV attack destroys immune innocence.
Superinfection (Reinfection): New Study in San Francisco Offers Free Resistance and Viral Load Testing.
HIV drug resistance testing: data be damned.
HIV Resistance: Data and spin.
Measles found to suppress HIV.
"Shy" study suggests new treatment mechanism.
Treatment interruption: most patients could not maintain immune control.
Tat inhibitors, a new approach: interview with Olaf Kutsch, Ph.D.
Major study of "discordant" response--viral control but incomplete CD4 response.
Plumbing HIV pathogenesis.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters